Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UR-1505 ointment dose-ranging trial in mild to moderate plaque psoriasis
2007-005672-13Phase 2Active
- Sponsor
- Palau Pharma
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of UR-1505 in psoriasis, sponsored by Palau Pharma. Started Nov 2007; status: active.
02
Drugs
UR-1505
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2007-005672-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005672-13.